Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ABX-002
ABX-002
Autobahn’s road to a breakthrough depression treatment is paved with high-profile investors
Pharma Voice
Wed, 08/7/24 - 11:22 am
Autobahn Therapeutics
depression
ABX-002
major depressive disorder
Autobahn raises $100M on investor interest in neuropsych drugs
BioPharma Dive
Thu, 07/25/24 - 11:09 am
Autobahn Therapeutics
major depressive disorder
bipolar disorder
funding
ABX-002